Compare LCNB & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCNB | MASS |
|---|---|---|
| Founded | 1877 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.1M | 224.0M |
| IPO Year | N/A | 2020 |
| Metric | LCNB | MASS |
|---|---|---|
| Price | $17.57 | $6.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 27.1K | ★ 378.4K |
| Earning Date | 01-29-2026 | 03-03-2026 |
| Dividend Yield | ★ 4.99% | N/A |
| EPS Growth | ★ 68.04 | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $90,061,000.00 | $65,045,000.00 |
| Revenue This Year | $8.39 | N/A |
| Revenue Next Year | $4.07 | $19.55 |
| P/E Ratio | $10.82 | ★ N/A |
| Revenue Growth | 13.66 | ★ 36.21 |
| 52 Week Low | $13.34 | $1.92 |
| 52 Week High | $17.84 | $9.34 |
| Indicator | LCNB | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 61.78 | 54.42 |
| Support Level | $16.77 | $6.06 |
| Resistance Level | $17.75 | $6.90 |
| Average True Range (ATR) | 0.42 | 0.39 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 90.51 | 46.08 |
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.